share_log
Moomoo 24/7 ·  Apr 22 08:00
Corcept Announces Positive Results From Open-Label Portion of Pivotal Phase 3 Grace Trial in Patients With Cushing’s Syndrome
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment